Liquid Biopsy Market In 2022 : Research Insights with Upcoming Trends, Opportunities, Competitive Analysis, Forecast 2030

 


Global Liquid Biopsy Market Size and Revenue Forecasts to 2030

The global liquid biopsy market size is expected to reach USD 7,645.0 Million in 2030 and register a revenue CAGR of 20.3% over the forecast period, according to the latest analysis by Emergen Research.. The research study also provides a complete analysis of the market drivers, restraints, limitations, threats, risks, and growth opportunities.

In addition, growing popularity of non-invasive techniques is driving private and public financing for research in the field of liquid biopsy, which allow medical professionals to discover various aspects of a tumor through a patient’s blood sample. Increased adoption of liquid biopsy in cancer is due to its potential for non-invasive detection of targeted genomic alteration in correspondence to targeted therapy. Non-cancerous application of liquid biopsy includes diagnosis of heart attack and atherosclerosis.

Academic researchers from various areas of expertise are working on developing, refining, and establishing clinical uses for liquid biopsy tests. For instance, InterVenn Biosciences announced completion of USD 201 million Series C financing in August 2021.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/34

The report offers a panoramic view of the competitive landscape of the industry and a detailed analysis of the key players of the market based on their revenue, profit margins, financial standing, global market position, R&D activities, and product portfolio. It also covers their strategic endeavors such as mergers and acquisitions, joint ventures, collaborations, partnerships, corporate and government deals, and product launches and brand promotions, among others Some companies in the global market report include Bio-Rad Laboratories, Inc., Adaptive Biotechnologies, NeoGenomics Laboratories, Guardant Health, Biocept, Inc., QIAGEN, F. Hoffmann-La Roche Ltd., MDxHealth, Menarini Silicon Biosystems, and Agena Bioscience, Inc.

Emergen Research has segmented the global liquid biopsy market based on product type, circulating biomarkers, sample type, technology, disease, application, end-use, and region:

  • Product Type Outlook (Revenue, USD Million; 2019–2030)
    • Assays Kits
    • Instruments
    • Services
  • Circulating Biomarkers Outlook (Revenue, USD Million; 2019–2030)
    • Circulating Tumor DNA (ctDNA)
    • Circulating Tumor Cells (CTCs)
    • Extracellular Vesicles (EVs)
    • Cell-Free DNA (cfDNA)
    • Others
  • Sample Type Outlook (Revenue, USD Million; 2019–2030)
    • Blood Sample
    • Urine Sample
    • Others
  • Technology Outlook (Revenue, USD Million; 2019–2030)
    • Multi-gene-parallel Analysis (NGS)
    • Single Gene Analysis (PCR Microarrays)
  • Disease Outlook (Revenue, USD Million; 2019–2030)
    • Oncology
      1. Breast Cancer
      2. Lung Cancer
      3. Prostate Cancer
      4. Colorectal Cancer
      5. Melanoma Cancer
      6. Others
    • Non-cancer
  • Application Outlook (Revenue, USD Million; 2019–2030)
    • Early Cancer Screening
    • Therapy Selection
    • Treatment Monitoring
    • Recurrence Monitoring Orthopedics
  • End-Use Outlook (Revenue, USD Million; 2019–2030)
    • Hospitals & Physician Laboratories
    • Reference Laboratories
    • Academic & Research Centers
    • Others

To know more about the report, visit @ https://www.emergenresearch.com/industry-report/liquid-biopsy-market

Regional Analysis of the Liquid Biopsy Market Includes:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

The report offers a complete understanding of the liquid biopsy market in key regions with respect to regional production and consumption patterns, import/export, supply and demand dynamics, trends, growth prospects, and the presence of prominent players in each region. Each of the mentioned regions is analyzed based on the comprehensive market data obtained from the major countries of each region to impart a clear understanding of the market.

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/34

Thank you for reading our report. To request a customization or for further inquiries, kindly get in touch with us. Our team will ensure the report is tailored meet to your needs.

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

 

 

 

Comments

Popular posts from this blog

Assessment Services Market Analysis, Key Company Profiles, Types, Applications and Forecast To 2030

Smart Contact Lens Market Share To Witness an Outstanding Growth by 2027

Women’s Health Market Research Report : Predictable To Exceed Market Income, Shares and Competitive Landscape 2027